Trial intelligence / Profile preview

Prednisolone vs etoricoxib vs indomethacin for acute gout arthritis

ChiCTR-IPR-15006269Phase 4Not yet recruiting

Sponsor
Nanfang Hospital, Southern Medical University
Start
Apr 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in gout comparing Prednisolone group, Etoricoxib group and Indomethacin group (3 arms). Primary endpoint: Joint pain intensity. Planned start Apr 2015; status: not yet recruiting.

02

Drugs

prednisoloneetoricoxibindomethacin
03

Conditions

gout

Beyond the preview

Go deeper on ChiCTR-IPR-15006269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15006269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call